First-line steroid treatment for spontaneous intracranial hypotension.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
03 2022
Historique:
revised: 31 10 2021
received: 05 05 2021
accepted: 18 11 2021
entrez: 10 2 2022
pubmed: 11 2 2022
medline: 5 4 2022
Statut: ppublish

Résumé

Spontaneous intracranial hypotension (SIH) is a syndrome characterized by low cerebrospinal fluid (CSF) pressure and postural headaches, and affects 1 per 20,000 individuals every year. We report an otherwise healthy 38-year-old man admitted to the hospital with orthostatic headache that developed 48 h after a short-haul flight during which he sustained a neck injury due to turbulence. Neurological examination, blood analysis and computed tomography scan performed at the emergency service were normal. Brain and spine magnetic resonance imaging (MRI) showed diffuse pachymeningeal enhancement and contrast medium egress from the subarachnoid space into the epidural space at the level of C2. The patient was treated with bed rest, hydration and 1 mg/kg/day oral prednisone for 5 days, with a gradual withdrawal in the following 7 days. Complete symptomatic relief was observed after 16 days, with resolution of the pathological findings on brain and spinal MRI after 1 month, except for localized pachymeningeal enhancement. Clinical relief was maintained over time until last follow-up visit 9 months later. Successful conservative treatment barely exceeds one quarter of cases of SIH. The clinical benefits of steroids may result from several mechanisms of action, for example, improving brain oedema and inflammation, determining fluid retention, and facilitating reabsorption of the CSF from extradural space. Notwithstanding that epidural blood patch remains the most successful treatment for SIH, future studies should explore the effectiveness of steroids as first-line therapy in addition to the most commonly suggested measures of bed rest and hydration.

Sections du résumé

BACKGROUND
Spontaneous intracranial hypotension (SIH) is a syndrome characterized by low cerebrospinal fluid (CSF) pressure and postural headaches, and affects 1 per 20,000 individuals every year.
CASE REPORT
We report an otherwise healthy 38-year-old man admitted to the hospital with orthostatic headache that developed 48 h after a short-haul flight during which he sustained a neck injury due to turbulence. Neurological examination, blood analysis and computed tomography scan performed at the emergency service were normal. Brain and spine magnetic resonance imaging (MRI) showed diffuse pachymeningeal enhancement and contrast medium egress from the subarachnoid space into the epidural space at the level of C2. The patient was treated with bed rest, hydration and 1 mg/kg/day oral prednisone for 5 days, with a gradual withdrawal in the following 7 days. Complete symptomatic relief was observed after 16 days, with resolution of the pathological findings on brain and spinal MRI after 1 month, except for localized pachymeningeal enhancement. Clinical relief was maintained over time until last follow-up visit 9 months later.
CONCLUSION
Successful conservative treatment barely exceeds one quarter of cases of SIH. The clinical benefits of steroids may result from several mechanisms of action, for example, improving brain oedema and inflammation, determining fluid retention, and facilitating reabsorption of the CSF from extradural space. Notwithstanding that epidural blood patch remains the most successful treatment for SIH, future studies should explore the effectiveness of steroids as first-line therapy in addition to the most commonly suggested measures of bed rest and hydration.

Identifiants

pubmed: 35141990
doi: 10.1111/ene.15195
pmc: PMC9303736
doi:

Substances chimiques

Steroids 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

947-949

Informations de copyright

© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Front Neurol. 2018 Aug 17;9:673
pubmed: 30174645
Eur J Neurol. 2022 Mar;29(3):947-949
pubmed: 35141990
JAMA Neurol. 2021 Mar 1;78(3):329-337
pubmed: 33393980
Nagoya J Med Sci. 2016 May;78(2):229-36
pubmed: 27303109
Neurology. 2016 Aug 16;87(7):673-9
pubmed: 27440149
Pol J Radiol. 2018 May 22;83:e229-e233
pubmed: 30627240

Auteurs

Simone Tonello (S)

Neurology Unit, Regional Hospital Treviso, Treviso, Italy.

Ugo Grossi (U)

II Surgery Unit, Regional Hospital Treviso, Treviso, Italy.
Department of Surgery, Oncology and Gastroenterology - DISCOG, University of Padua, Padova, Italy.

Elena Trincia (E)

Neuroradiology Unit, Regional Hospital Treviso, Treviso, Italy.

Giacomo Zanus (G)

II Surgery Unit, Regional Hospital Treviso, Treviso, Italy.
Department of Surgery, Oncology and Gastroenterology - DISCOG, University of Padua, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH